| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Gallagher Carol Giltner is a Director at ANAB, with reported holdings spanning 4 companies. Recent filings cover 3 purchases and 26 sales.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 14, 2023 | ATRA Atara Biotherapeutics, Inc. | - | Buy | 270,000 | $0.25 | $68,214.48 | +142.5% | +140.7% | +64.0% | |
| Nov 7, 2018 | ATRA Atara Biotherapeutics, Inc. | Director | Sell | 21,374 | $36.38 | $777,586.12 | -19.4% | - | - | |
| Jun 18, 2018 | ATRA Atara Biotherapeutics, Inc. | Director | Sell | 2,500 | $44.78 | $111,944.00 | -2.2% | - | - | |
| May 16, 2018 | ATRA Atara Biotherapeutics, Inc. | Director | Sale+OE | 273 | $46.06 | $12,574.38 | -0.2% | - | - | |
| Feb 16, 2018 | ATRA Atara Biotherapeutics, Inc. | Director | Sale+OE | 1,183 | $46.50 | $55,009.50 | -1.1% | - | - | |
| Nov 16, 2017 | ATRA Atara Biotherapeutics, Inc. | Director | Sale+OE | 1,184 | $14.20 | $16,812.80 | -1.1% | - | - | |
| Aug 16, 2017 | ATRA Atara Biotherapeutics, Inc. | Director | Sale+OE | 1,184 | $14.30 | $16,931.20 | -1.1% | - | - | |
| Jun 9, 2017 | ATRA Atara Biotherapeutics, Inc. | Director | Sell | 1,000 | $13.15 | $13,150.00 | -0.9% | - | - | |
| May 16, 2017 | ATRA Atara Biotherapeutics, Inc. | Director | Sale+OE | 1,184 | $15.25 | $18,056.00 | -1.1% | - | - | |
| Feb 16, 2017 | ATRA Atara Biotherapeutics, Inc. | Director | Sale+OE | 1,183 | $16.10 | $19,046.30 | -1.1% | - | - |